Medicine and Dentistry
Patient
100%
COVID-19
61%
Malignant Neoplasm
45%
Patient with Cancer
38%
Infection
31%
Mortality
29%
Inpatient
28%
Hematologic Malignancy
23%
Hematopoietic Cell
21%
Therapeutic Procedure
20%
Transplantation
20%
Lower Respiratory Tract Infection
18%
Hispanic
16%
Hematopoietic Stem Cell
15%
Diagnosis
15%
Odds Ratio
13%
Vaccine
13%
Stem Cell Transplant
12%
Age
11%
Influenza
11%
Respiratory Syncytial Virus Infection
10%
Human Respiratory Syncytial Virus
10%
Cohort Analysis
10%
All Cause Mortality
10%
Microbiome
10%
Ribavirin
10%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Association
9%
Viral Respiratory Tract Infection
9%
Incidence
9%
Cancer Treatment
8%
Morbidity
8%
Immunosuppressive Treatment
8%
Antiviral Therapy
7%
Prostate Cancer
7%
Surveillance
7%
Diseases
7%
Human Metapneumovirus Infection
7%
Male
7%
Analysis
6%
Laboratory
6%
Retrospective Study
6%
Cardiovascular System
6%
Upper Respiratory Tract Infection
6%
Combination Therapy
6%
Cell Transplantation
6%
Logistic Regression Analysis
6%
Mixed Infection
6%
Complication
6%
Lymphoma
5%
Immunology and Microbiology
Human Respiratory Syncytial Virus
47%
Transplantation
45%
Cells
45%
Lower Respiratory Tract
31%
Cytomegalovirus
30%
Mortality
29%
Viral Disease
19%
Respiratory Syncytial Virus Infection
18%
Monospecific Antibody
16%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Immunodeficiency
15%
Ribavirin
14%
COVID-19
13%
Vaccine Efficacy
12%
Cytomegalovirus Infection
11%
Viral Clearance
11%
Influenza
10%
Hepatitis C Virus
10%
Cell Transplantation
10%
Morbidity
10%
Genotype
9%
Sample
9%
Upper Respiratory Tract
9%
Incidence
8%
Antibody Response
8%
Palivizumab
8%
Hematopoietic Stem Cell Transplantation
8%
Dose
7%
Immunosuppression
6%
Human Respiratory Syncytial Virus A
6%
High Risk Population
6%
Coinfection
6%
Age
6%
Neutralizing Antibody
6%
Time
5%
Leflunomide
5%
Human Metapneumovirus
5%
Stem Cell Transplant
5%
Immunotherapy
5%
Hepatitis B Virus
5%
Pharmacology, Toxicology and Pharmaceutical Science
Lower Respiratory Tract Infection
27%
Mortality
20%
Ribavirin
19%
Human Respiratory Syncytial Virus
18%
Malignant Neoplasm
18%
Infection
16%
Hematologic Malignancy
16%
Respiratory Syncytial Virus Infection
16%
Drug
13%
Vaccine
12%
Immune Deficiency
11%
Cytomegalovirus
9%
Hepatitis C Virus
8%
Upper Respiratory Tract Infection
7%
Morbidity
7%
Viral Clearance
7%
Influenza
6%
Cytomegalovirus Infection
6%
Incidence
5%
Antiviral Therapy
5%
Leflunomide
5%
Amphotericin B
5%
Hepatitis B
5%
Mixed Infection
5%
Immunotherapy
5%
All Cause Mortality
5%
Death
5%
